J Endocr Surg.  2019 Dec;19(4):159-161. 10.16956/jes.2019.19.4.159.

Recommended Surgery for >1 cm Noninvasive Follicular Neoplasia with Papillary-Like Nuclear Features (NIFTP)

Affiliations
  • 1Division for Endocrine and Minimally Invasive Surgery, Department of Human Pathology in Adulthood and Childhood “G. Barresi”, University Hospital G. Martino, University of Messina, Messina, Italy. alessandro.pontin1990@gmail.com

Abstract

Papillary thyroid carcinoma (PTC) is a heterogeneous tumor group with differing pathogenesis and prognosis of the individual subtypes. In addition, a tumor entity has been spun off, now referred to as "noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP). A recent study, based on a comprehensive evaluation of a prospective multicenter NIFTP-based retrospective study, was intended to clarify whether NIFTP can metastasize and thus justify a reduced resection rate compared to classical PTC. For 3 reasons, Authors nicely recommend caution regarding a limited thyroid procedure (i.e. lobectomy vs. completion thyroidectomy): i) In the current literature, lymph node metastases have been described in 10 patients with NIFTP, and in 1 patient lung metastases. ii) As reported for the first time in this study, nearly one-fifth of patients have NIFTP-associated PTMC with unclear potential for metastasis. iii) Observation periods are still relatively short and so far, there are no agreed follow-up standards.

Keyword

Thyroid surgery; Noninvasive follicular neoplasia; Papillary-like nuclear features; Thyroid gland

MeSH Terms

Follow-Up Studies
Humans
Lung
Lymph Nodes
Neoplasm Metastasis
Prognosis
Prospective Studies
Retrospective Studies
Thyroid Gland
Thyroid Neoplasms

Reference

1. Dralle H. Can noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) metastasize? Chirurg. 2019; 90:501.
2. Chereau N, Greilsamer T, Mirallié E, Sadowski SM, Pusztaszeri M, Triponez F, et al. NIFT-P: are they indolent tumors? Results of a multi-institutional study. Surgery. 2019; 165:12–16.
Article
3. Xu B, Farhat N, Barletta JA, Hung YP, Biase D, Casadei GP, et al. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category? Endocrine. 2018; 59:143–150.
Article
4. Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment. Mod Pathol. 2016; 29:698–707.
Article
5. Xu B, Tallini G, Scognamiglio T, Roman BR, Tuttle RM, Ghossein RA. Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017; 27:512–517.
Article
6. Thompson LD, Poller DN, Kakudo K, Burchette R, Nikiforov YE, Seethala RR. An international interobserver variability reporting of the nuclear scoring criteria to diagnose noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a validation study. Endocr Pathol. 2018; 29:242–249.
Article
7. Hirokawa M, Higuchi M, Suzuki A, Hayashi T, Kuma S, Miyauchi A. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan. Endocr J. 2017; 64:1149–1155.
Article
Full Text Links
  • JES
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr